There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez \& Tulandi, 2017). A variety of medical and surgical treatment modalities for CSP have been reported; however, most of these are based on low-level evidence(Sun et al., 2019).
This will be a randomized clinical trial to evaluate the effect of administration of methotrexate before surgery in reducing bleeding, injury to bladder and ureter, operative time and removing of CSP mass.This will be in comparison to surgery alone in cases of first trimester cesarean scar pregnancy
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
56
giving methotrexate at least 1 w week before surgery
Mansoura University
Al Mansurah, Dakahliya, Egypt
RECRUITINGEstimated blood loss intraoperative
the amount of blood in soaked towels and vacuum aspiration
Time frame: intraoperative blood loss
need further management
Time frame: 1 month
• Rate of urological injury
Time frame: immediatly and 1 week post operative
• Rate of readmission, relaparotomy
Time frame: with in 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.